Prakiraan pendapatan perusahaan: Solid Bio (SLDB)
The target sales volume indicator reflects market growth expectations, where the value 0.00 serves as the target level. Solid Biosciences Inc. (SLDB) is attracting leading geneticists, securing staff through stock options. Financial stability is based on grants and partnerships amid negative FCF. The primary threat remains potential therapy side effects, which could wipe out the company's capitalization.
Ringkesan rincian data analitis Solid Corp (SLDB)
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Total Utang marang Modal Solid Biosciences Inc.|SLDB - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Solid Biosciences|SLDB - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Solid Biosciences|SLDB - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Solid Biosciences|Likuiditas cepet solidbio.com
- statistik bathi lan rasio pasar:
SLDB - Asil keuangan resik|Bathi mangsa ngarep Solid Biosciences Inc.|SLDB - Nilai perusahaan marang bathi resik|Pangali Forward P/E Solid Corp|SLDB - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Solid Biosciences Inc.|SLDB - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Solid Biosciences|SLDB - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan solidbio.com|SLDB - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Solid Biosciences Inc.
- data total pendapatan lan volume dodolan:
Ringkesan analitik perusahaan:Solid Biosciences Inc
This indicator measures market expectations for future revenue, reflecting the analysts' consensus forecast regarding the business's ability to generate cash flow over the long term. For Solid Biosciences Inc. (SLDB), the trend of prospective sales is critically dependent on the reliability of external CMO contractors, as the lack of in-house capacity makes any gene therapy implementation forecasts sensitive to the operational risks of outsourcing.
Pesaing Solid Biosciences Inc.
Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan RARE (Ultragenyx)|Volume dodolan mangsa ngarep perusahaan BEAM|Prakiraan volume dodolan Sarepta Corp|Prakiraan pendapatan perusahaan Twist Bioscience, Inc. (TWST)|Volume dodolan mangsa ngarep perusahaan 10x Genomics TXG|Prakiraan pendapatan perusahaan Intellia Therapeutics NTLA|Prakiraan volume pendapatan perusahaan STOK (Stoke Therapeutics, Inc.)|BLFS - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Wave Pharma|mazetx.com (MAZE) - Prakiraan pendapatan perusahaan|SION - Dodolan mangsa ngarep perusahaan|PRME (Prime Medicine Inc) - Prakiraan volume dodolan|Taysha Gene Therapies, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan QURE|MGTX: Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan REGENXBIO RGNX|OCGN - Volume dodolan mangsa ngarep perusahaan|pacb.com - Prakiraan volume dodolan|Benitec (BNTC) - Volume dodolan mangsa ngarep perusahaan|DSGN: Prakiraan volume dodolan|RCKT - Dodolan mangsa ngarep perusahaan|FDMT: Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan LXEO (lexeotx.com)|Prakiraan pendapatan perusahaan Korro Bio Inc. (KRRO)|Prakiraan volume pendapatan perusahaan EDIT|Prakiraan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan mangsa ngarep perusahaan PRQR|CDXS - Prakiraan pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Prakiraan pendapatan perusahaan|NAUT: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan MGX|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan
